These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 10795142)

  • 21. Metabolic syndrome: treatment of hypertensive patients.
    Israili ZH; Lyoussi B; Hernández-Hernández R; Velasco M
    Am J Ther; 2007; 14(4):386-402. PubMed ID: 17667215
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of meal replacement on metabolic risk factors in overweight and obese subjects.
    König D; Deibert P; Frey I; Landmann U; Berg A
    Ann Nutr Metab; 2008; 52(1):74-8. PubMed ID: 18319587
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Moxonidine in the treatment of overweight and obese patients with the metabolic syndrome: a postmarketing surveillance study.
    Sharma AM; Wagner T; Marsalek P
    J Hum Hypertens; 2004 Sep; 18(9):669-75. PubMed ID: 15269705
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Nutritional knowledge of patients in the hypertension clinic. An evaluation using the "Nutrition IQ'].
    Suter PM; Holm D; Vetter W
    Praxis (Bern 1994); 1995 Jan; 84(1):16-21. PubMed ID: 7839039
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Obesity and cardiovascular diseases-theoretical background and therapeutic consequences].
    Völler H; Schmailzl KJ; Bjarnason-Wehrens B
    Z Kardiol; 2004 Jul; 93(7):503-13. PubMed ID: 15243761
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of cocoa flavanols and exercise on cardiometabolic risk factors in overweight and obese subjects.
    Davison K; Coates AM; Buckley JD; Howe PR
    Int J Obes (Lond); 2008 Aug; 32(8):1289-96. PubMed ID: 18504447
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Relationship between obesity and arterial hypertension].
    Cambien F
    Nouv Presse Med; 1982 Dec; 11(49):3641-6. PubMed ID: 7162965
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of hypertension in chronic kidney disease.
    Toto RD
    Semin Nephrol; 2005 Nov; 25(6):435-9. PubMed ID: 16298269
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The PREMIER intervention helps participants follow the Dietary Approaches to Stop Hypertension dietary pattern and the current Dietary Reference Intakes recommendations.
    Lin PH; Appel LJ; Funk K; Craddick S; Chen C; Elmer P; McBurnie MA; Champagne C
    J Am Diet Assoc; 2007 Sep; 107(9):1541-51. PubMed ID: 17761231
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Obesity-related hypertension].
    Ueda Y; Aoi W
    Ryoikibetsu Shokogun Shirizu; 1996; (12):163-6. PubMed ID: 9047433
    [No Abstract]   [Full Text] [Related]  

  • 31. Salt intake and hypertension therapy.
    Milan A; Mulatero P; Rabbia F; Veglio F
    J Nephrol; 2002; 15(1):1-6. PubMed ID: 11936420
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effects of a low-fat, plant-based dietary intervention on body weight, metabolism, and insulin sensitivity.
    Barnard ND; Scialli AR; Turner-McGrievy G; Lanou AJ; Glass J
    Am J Med; 2005 Sep; 118(9):991-7. PubMed ID: 16164885
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical evidence for drug treatments in obesity-associated hypertensive patients--a discussion paper.
    Doggrell SA
    Methods Find Exp Clin Pharmacol; 2005 Mar; 27(2):119-25. PubMed ID: 15834464
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Exercise-induced reduction in obesity and insulin resistance in women: a randomized controlled trial.
    Ross R; Janssen I; Dawson J; Kungl AM; Kuk JL; Wong SL; Nguyen-Duy TB; Lee S; Kilpatrick K; Hudson R
    Obes Res; 2004 May; 12(5):789-98. PubMed ID: 15166299
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Overweight, obesity, and blood pressure: the effects of modest weight reduction.
    Mertens IL; Van Gaal LF
    Obes Res; 2000 May; 8(3):270-8. PubMed ID: 10832771
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Nonpharmacological factors in the treatment of arterial hypertension. The roll of obesity, alcohol consumption and table salt intake].
    Luft FC; Geiger H; Schmieder R; Mann J
    Dtsch Med Wochenschr; 1992 Jan; 117(4):145-9. PubMed ID: 1733699
    [No Abstract]   [Full Text] [Related]  

  • 37. The influence of obesity and consequent insulin resistance on coronary risk factors in medically treated patients with coronary disease.
    Ades PA; Savage PD; Toth MJ; Schneider DJ; Audelin MC; Bunn JY; Ludlow M
    Int J Obes (Lond); 2008 Jun; 32(6):967-74. PubMed ID: 18268512
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The future of antihypertensive treatment.
    Israili ZH; Hernández-Hernández R; Valasco M
    Am J Ther; 2007; 14(2):121-34. PubMed ID: 17414579
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Overweight, obesity and elevated blood pressure in children and adolescents.
    Schiel R; Beltschikow W; Kramer G; Stein G
    Eur J Med Res; 2006 Mar; 11(3):97-101. PubMed ID: 16751109
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A reduced-glycemic load diet in the treatment of adolescent obesity.
    Ebbeling CB; Leidig MM; Sinclair KB; Hangen JP; Ludwig DS
    Arch Pediatr Adolesc Med; 2003 Aug; 157(8):773-9. PubMed ID: 12912783
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.